4/A

AMENDMENT TO OWNERSHIP DOCUMENT

Company: Karyopharm Therapeutics Inc.
Filed: July 28, 2014
Period of Report: July 23, 2014
Accession Number: 0001213900-14-005161

View Document ↗ View on SEC.gov ↗